Building Breakthroughs with Strategic Partnerships

From government grants to global licensing.

Contact

Green microscopic organism with textured surface and smaller structures surrounding it on a black background.

Watch Commercial

Partner With Us

With over $40M in U.S. and Canadian government grants, we’re bringing WST-057 — the first topical treatment designed to regrow peripheral nerves — to patients worldwide. We welcome innovators, research institutions, and pharmaceutical leaders to join us in transforming care.

Market Insight & Opportunity

Partnership & Licensing Strategy

Regulatory & Clinical Expertise

Intellectual property

Scientist wearing safety goggles and blue lab attire, using a pipette to transfer liquid into a vial in a laboratory setting.

We help partners identify high-impact market opportunities for nerve regeneration therapies, combining deep knowledge of disease prevalence, competitive landscapes, and emerging healthcare needs. Our insights enable precise positioning of licensed products for maximum adoption and long-term success.

Epidemiology & Demand Forecasting – Quantifying unmet patient needs across global markets.

Competitive Intelligence – Understanding existing treatment gaps and positioning advantages.

Trend Analysis – Tracking shifts in healthcare policy, reimbursement, and prescribing behavior.

Market Insight & Opportunity

Partnership & Licensing Strategy

Regulatory & Clinical Expertise

Intellectual property

We help partners identify high-impact market opportunities for nerve regeneration therapies, combining deep knowledge of disease prevalence, competitive landscapes, and emerging healthcare needs. Our insights enable precise positioning of licensed products for maximum adoption and long-term success.

Epidemiology & Demand Forecasting – Quantifying unmet patient needs across global markets.

Competitive Intelligence – Understanding existing treatment gaps and positioning advantages.

Trend Analysis – Tracking shifts in healthcare policy, reimbursement, and prescribing behavior.

Market Insight & Opportunity

Partnership & Licensing Strategy

Regulatory & Clinical Expertise

Intellectual property

We help partners identify high-impact market opportunities for nerve regeneration therapies, combining deep knowledge of disease prevalence, competitive landscapes, and emerging healthcare needs. Our insights enable precise positioning of licensed products for maximum adoption and long-term success.

Epidemiology & Demand Forecasting – Quantifying unmet patient needs across global markets.

Competitive Intelligence – Understanding existing treatment gaps and positioning advantages.

Trend Analysis – Tracking shifts in healthcare policy, reimbursement, and prescribing behavior.

Strategic partnerships between institutions, biotech companies, and investors.

Why partner with WinSanTor?

Breakthrough Science

We are developing WST-057, the first topical treatment designed to regrow peripheral nerves — backed by a patented mechanism of action and exclusive rights across the therapeutic category. Our science is poised to redefine how peripheral neuropathy is treated, creating an entirely new market for partners to lead.

Proven Credibility

With over $40 million in U.S. and Canadian government grants and a licensing agreement with Japan’s leading dermatology company, we bring a track record of global recognition, non-dilutive funding, and high-value partnerships that de-risk collaboration.

Exclusive Market Advantage

Our IP portfolio secures complete control over WST-057’s mechanism of action and therapeutic category, giving partners unrivaled exclusivity. Combined with our regulatory, commercialization, and provider network expertise, we accelerate market entry and adoption.